New Square Capital LLC Nektar Therapeutics Transaction History

New Square Capital LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2020 Aug 05, 2020	SELL	$16.86 - $23.44 $67,440 - $93,760	-4,000 Closed	0 $0
Q1 2020 May 08, 2020	BUY	$14.47 - $27.96 $57,880 - $111,840	4,000 New	4,000 $71,000
Q3 2019 Oct 15, 2019	SELL	$16.91 - $36.27 $67,640 - $145,080	-4,000 Closed	0 $0
Q3 2017 Nov 07, 2017	BUY	$17.79 - $24.0 $71,160 - $96,000	4,000	4,000 $96,000

128

111M

150K

Ticker NKTR
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 187,404,992
Market Cap $244M
Description
Nektar Therapeutics, a biopharmaceutical company, focuses on discovering and developing medicines in areas of unmet medical need in the United States and internationally. The company's products include Bempegaldesleukin, a CD122-preferential interleukin-2 (IL-2) pathway agonist, which is in phase 3 clinical trial to treat metastatic melanoma, re...

Get notified when there are updates to the investment portfolio of New Square Capital LLC, based on Form 13F filings with the SEC.

Stay updated on New Square Capital LLC with notifications on news.